Outcome of @entity3446 therapy for XXXX after kidney transplantation: case series.

@entity3446 @entity1 @entity1071 @entity706
BACKGROUND: @entity1071 ( @entity1071 ) are a complication of chronic immunosuppressive therapy in solid organ transplantation with a high mortality rate. Alternative treatments such as @entity3446 have been explored. METHODS: A detailed retrospective analysis was performed according to data collected from 13 @entity1 with @entity1071 . At the time of @entity1071 diagnosis, immunosuppressive therapy was decreased and @entity3446 administered. Overall survival, disease-free survival of @entity1 and graft survival were determined. RESULTS: Among 590 kidney transplant recipients, 13 adult @entity1 with @entity1071 were included in this study. The mean age of the @entity1 was 42.15 (range: 25-58) years at the time of @entity1071 diagnosis, and 9 @entity1 were male. Histology was distributed in 9 diffuse large B cell, 1 @entity706 , 1 @entity1071 . The response rate to @entity3446 alone was 30.8%. The mean overall survival period was 23.38 months and 11 @entity1 are still alive. In total, 10 @entity1 (76.9%) achieved a complete remission with functioning graft in 11 (84.6%) @entity1 . CONCLUSION: Despite the retrospective focus and limited number of @entity1 , this study provides promising results regarding the effectiveness of stopping calcineurin inhibitors and switching to @entity3446 for @entity1 with @entity1071 .
